ICD-10-CM Billable Code

M08.252

Juvenile rheumatoid arthritis with systemic onset, left hip

Clinical Classification Guidelines

Medical Intelligence & Overview

Juvenile Rheumatoid Arthritis (JRA), also known as Juvenile Idiopathic Arthritis, is a chronic autoimmune condition that affects children. The subtype characterized by systemic onset involves inflammation that can affect multiple parts of the body, including joints, organs, and the immune system. Specifically, when this condition impacts the left hip, it can lead to pain, swelling, and reduced mobility, impacting a child's daily activities and overall well-being.

Causes & Symptoms

Clinical Causes: The exact cause of juvenile rheumatoid arthritis with systemic onset remains unknown. It is believed to result from an abnormal immune response where the body's immune system attacks its own tissues. Genetic predisposition may play a role, as children with family histories of autoimmune diseases are at higher risk. Environmental factors, such as infections, have been proposed as potential triggers, but conclusive evidence is lacking.

Key Symptoms: Persistent fever that may spike daily, often accompanied by a rash. Swelling and pain in the affected joint(s), notably in the left hip in this case. Morning stiffness lasting more than an hour, affecting movement and function. Fatigue and general malaise. Enlargement of lymph nodes, liver, or spleen in some cases. Loss of appetite and weight loss due to systemic inflammation. Potential anemia contributing to tiredness.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. A healthcare provider will assess symptoms, perform a physical exam focusing on joint swelling and range of motion, and may order blood tests such as ESR and CRP to detect inflammation. Imaging studies like X-rays or MRI scans can help evaluate joint damage and inflammation specific to the left hip. There is no single definitive lab test for JRA, so diagnosis relies on ruling out other conditions and identifying characteristic features of the disease.

Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, to slow disease progression. Biologic agents targeting specific immune pathways may be considered for more severe cases. Physical therapy and occupational therapy to maintain joint function and improve mobility. Regular exercise and activity adjustments to prevent stiffness and muscle weakness. Monitoring and managing systemic symptoms like fever and fatigue.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.252 a billable ICD-10 code?
Yes, M08.252 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.252?
Clinical documentation must specify the nature of Juvenile rheumatoid arthritis with systemic onset, left hip and any associated comorbidities for accurate reporting.

Cite this Clinical Reference